Your gateway to the world of medicine
Cancer News
About Us
Health Professionals
Patients and public
Contact Us

BRCA research information

From BRCA research information

Breast cancer treatment Breast cancer main Breast cancer news  

  • Two The presence of hereditary BRCA1 gene mutations in women with familial breast or ovarian cancer

  • Outcome of five years of accelerated surveillance in patients at high risk for inherited breast/ovarian cancer

  • Breast-feeding and the risk of breast cancer in BRCA1 and BRCA2

  • A new scoring system for the chances of identifying a BRCA1/2 mutation

  • Two Percent of Men with Early-Onset Prostate Cancer Harbor Germline Mutations in the BRCA2 Gene

  • BRCA1 and BRCA2 Germline Mutations in Lymphoma Patients

  • Fallopian Tube and Primary Peritoneal Carcinomas Associated With BRCA Mutations

  • Cancer Incidence in BRCA1 Mutation Carriers

  • Cancer Risk Estimates for BRCA1 Mutation Carriers Identified in a Risk Evaluation Program

  • BRCA2 Gene Mutations in Families With Aggregations of Breast and Stomach Cancers

  • The genetic attributable risk of breast and ovarian cancer

  • The Risk of Cancer Associated with Specific Mutations of BRCA1 and BRCA2 among Ashkenazi Jews

  • Frequency of BRCA1 and BRCA2 Mutations in Unselected Ashkenazi Jewish Patients With Colorectal Cancer

  • BRCA1 and BRCA2 Founder Mutations and the Risk of Colorectal Cancer

  • BRCA Mutations and Risk of Prostate Cancer in Ashkenazi Jews

  • Impact of Germline Brca1 Mutations and Overexpression of P53 on Prognosis and Response to Treatment Following Breast Carcinoma: 10-Year Follow-Up Data

  • Improved Survival in Women with BRCA-Associated Ovarian Carcinoma

  • BRCA1 Functions as a Differential Modulator of Chemotherapy-Induced Apoptosis

  • Effect of BRCA Mutations on the Length of Survival in Epithelial Ovarian Tumors

  • Outcome of Conservatively Managed Early-Onset Breast Cancer by Brca1/2 Status

  • Survival In Prospectively Ascertained Familial Breast Cancer: Analysis of a Series Stratified By Tumour Characteristics, Brca Mutations and Oophorectomy

  • A Genetic Epidemiological Study of Carcinoma of the Fallopian Tube

  • Risk of Endometrial Carcinoma Associated with BRCA Mutation

  • Clinical Characteristics of Individuals With Germline Mutations in BRCA1 and BRCA2: Analysis of 10,000 Individuals

  • A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment

  • Cancer Risks in BRCA2 Mutation Carriers

  • Variation in Cancer Risks, by Mutation Position, in BRCA2 Mutation Carriers

  • Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer Families

  • Breast Cancer Risk Assessment Models: Applicability to African-American women

  • Ovarian Cancer Risk in Ashkenazi Jewish Carriers of BRCA1 and BRCA2 Mutations

  • Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies

  • The Lifetime Risks of Breast Cancer in Ashkenazi Jewish Carriers of BRCA1 and BRCA2 Mutations

  • Modification of BRCA1- and BRCA2: Associated Breast Cancer Risk by AIB1 Genotypeand Reproductive History

  • On the Use of Familial Aggregation in Population-Based Case Probands for Calculating Penetrance

  • The Effectiveness of the Gail Model in Estimating Risk for Development of Breast Cancer in women under 40 years of age

  • Understanding Mathematical Models for Breast Cancer Risk Assessment and Counseling

  • Limitations of the Gail Model in the Specialized Breast Cancer Risk Assessment Clinic

  • BRCA2 Mutation Carriers, Reproductive Factors and Breast Cancer Risk

  • Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2

  • Effect of Radiotherapy After Breast-Conserving Treatment in Women With Breast Cancer and Germline BRCA1/2 Mutations

  • Prevalence of BRCA1 and BRCA2 germline mutations in young breast cancer patients: A population-based study

  • Long-Term Psychological Impact of Carrying a BRCA1/2 Mutation and Prophylactic Surgery: A 5-Year Follow-Up Study

  • Reproductive Factors and Ovarian Cancer Risk in Jewish BRCA1 And BRCA2 Mutation Carriers (United States)

  • Oral Contraceptives and the Risk of Hereditary Ovarian Cancer

  • Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

  • Tamoxifen and Risk of Contralateral Breast Cancer in BRCA1 And BRCA2 Mutation Carriers: A Case-Control Study

  • Smoking and the risk of breast cancer among carriers of BRCA mutations

  • Breast-feeding and the Risk of Breast Cancer in BRCA1 and BRCA2 Mutation Carriers

  • TGFBR1*6A and Cancer Risk: A Meta-Analysis of Seven Case-Control Studies

  • Life Insurance and Breast Cancer risk Assessment: Adverse Selection, Genetic Testing Decisions, and Discrimination

  • Preempting Genetic Discrimination and Assaults on Privacy: Report of a Symposium

  • Low-Penetrance Susceptibility to Breast Cancer Due to CHEK2*1100delC in Noncarriers of BRCA1 or BRCA2 Mutations

  • A CHEK2 Genetic Variant Contributing to a Substantial Fraction of Familial Breast Cancer

  • Frequency of CHEK2*1100delC in New York Breast Cancer Cases and Controls

  • Psychosocial Predictors of BRCA Counseling and Testing Decisions among Urban African-American Women

  • What Do Ratings of Cancer-Specific Distress Mean Among Women at High Risk of Breast and Ovarian Cancer?

  • Breast cancer genetics in African Americans

  • Tamoxifen and Breast Cancer Incidence Among Women With Inherited Mutations in BRCA1 and BRCA2

  • Bilateral Prophylactic Mastectomy Reduces Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study Group

  • Hormone Replacement Therapy and Life Expectancy After Prophylactic Oophorectomy in Women With Mutations: A Decision Analysis

  • Outcome of Preventive Surgery and Screening for Breast and Ovarian Cancer in BRCA Mutation Carriers

  • Effect of Prevention Strategies on Survival and Quality-Adjusted Survival of Women With BRCA1/2 Mutations: An Updated Decision Analysis

  • Genetic testing for a BRCA1 mutation: Prophylactic Surgery and Screening behavior in women 2 years post testing

  • Reoperations after prophylactic mastectomy with or without implant reconstruction

  • Effectiveness of Modena Surveillance Program for Women at Risk For Breast Cancer

  • Using Sonography to Screen Women with Mammographically Dense Breasts

  • MRI of Occult Breast Carcinoma in a High-Risk Population

  • American Cancer Society Guidelines for Breast Cancer Screening: Update 2003

  • Cancer Genetics Network Ovarian Screening Study: Physician Practice Patterns in Screening Women at High Risk for Ovarian Cancer

  • A Gonadotropin-Releasing Hormone Agonist (Gnrha)-Based Chemoprevention Regimen That Reduces Mammographic Density in Brca Carriers While Maintaining Good Quality of Life (Qol), Bone Density, and Reproductive Options

  • Efficacy of Bilateral Prophylactic Mastectomy in Women with a Family History of Breast Cancer

  • Breast Cancer after Prophylactic Bilateral Mastectomy in Women with a BRCA1 or BRCA2 Mutation

  • Effect of Fenretinide on Ovarian Carcinoma Occurrence

  • Oral Contraceptives and the Risk of Breast Cancer in BRCA1 and BRCA2 Mutation Carriers

  • Effects of Tamoxifen on Benign Breast Disease in Women at High Risk for Breast Cancer

  • Prophylactic Oophorectomy in Carriers of BRCA1 or BRCA2 Mutations

  • Risk-Reducing Salpingo-oophorectomy in Women with a BRCA1 or BRCA2 Mutation

  • Life Expectancy Gains From Cancer Prevention Strategies for Women With Breast Cancer and BRCA1 or BRCA2 Mutations

  • Tubal Ligation and Risk of Ovarian Cancer in Carriers of Brca1 or BRCA2 Mutations: A Case-Control Study

  • Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers

  • Did you know? Until recently breast cancer topped the list of leading causes of cancer deaths in women, but lately lung cancer has claimed the top position. BRCA research information

    BREAST CANCER MAIN| Home| Breast cancer news| Common terms| Breast cancer symptoms| Treatment by stage| Surgical treatment| Chemotherapy| Chemo drugs| Doxorubicin| Cyclophosphamide| Methotrexate| Hormonal therapy| Radiation therapy| Monoclonal therapy| High dose chemotherapy| Recurrent breast cancer| Bisphosphonates| Pregnancy and breast cancer| Risk factors| Risk details| My risk| Comprehensive| Breast cancer statistics| African Americans| Ashkenazi| Asians| Hispanic| Men| Native Americans| Older women| Younger women| Pregnant women| BRCA|

    Copyright statement
    The contents of this web page are protected. Legal action may follow for reproduction of materials without permission.